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This is the report on tuberculosis (TB) control for the WHO Western Pacific Region. It includes data
on estimates of disease burden, case notifications and treatment outcomes reported from 36 of 37
countries and areas in the Region in 2004. Regionally, tuberculosis remains a major public health
problem. In 2004, there were an estimated 3.8 million prevalent cases of TB (216 per 100 000
population) in the Region, of which almost 2 million were new cases (111 per 100 000 population).
Three countries (China, the Philippines and Viet Nam) accounted for about 90% of the total estimated
new cases in the Region. China accounted for 70% of incident TB cases (all forms) in the Region.
The human immunodeficiency virus (HIV) epidemic has had an impact in the Region:  the prevalence
of HIV among TB cases was 13% in Cambodia, 3.7% in Papua New Guinea and 3% in Viet Nam. In
addition, drug resistance was found in all settings surveyed in the Region; the prevalence of multidrug
resistant-tuberculosis (MDR-TB) in previously untreated cases varied widely across settings ranging
from 0.1% to 10.4%.
The case detection rate in the Region in 2004 (see Annex 1 for definitions) was 60% for all tuberculosis
cases and 67% for new smear-positive cases. In other words, the 1.2 million notified cases (all
types) represented 60% of the 2 million estimated cases (all types) and the 579 594 notified new
smear-positive cases represented 67% of the estimated new smear-positive cases. Based on
preliminary data, the Region has likely reached the 2005 case detection rate target of 70%.
Case detection rates in areas with directly observed treatment, short-course (DOTS) have been
steadily increasing in the Region since 2002. The 67% increase in case detection in the Region
from 2002 to 2004 is primarily due to a dramatic 110% increase in case detection in China.
In DOTS areas, the treatment cure and success rates were 87% and 91%, respectively, for the
cohort of 426 675 new pulmonary smear-positive cases registered for treatment in 2003. In the
Lao People’s Democratic Republic and Papua New Guinea, two countries with a high burden of
tuberculosis,1 treatment success rate were below the 85% WHO target.
In 2000, the Regional Committee for the Western Pacific endorsed the impact targets of 50% reduction
in prevalence and mortality due to TB within 10 years, by 2010. To achieve the impact targets by
2010, the Region needs to accelerate the rate of decline in prevalence and mortality by further
improving the quality of DOTS services, and by addressing the current challenges of MDR-TB and
HIV.
Executive Summary
1 Seven countries in the Western Pacific Region have a high burden of tuberculosis:  Cambodia, China, the Lao People’s
Democratic Republic, Mongolia, Papua New Guinea, the Philippines and Viet Nam
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The WHO Western Pacific Region covers a broad geographic area comprising more than 27% of
the world’s population, in 37 countries and areas.
In 2005, WHO sent a standard form for reporting surveillance data to all 37 countries and areas.
Information was collected about the number and types of tuberculosis (TB) cases notified in 2004,
on the outcomes of treatment among smear-positive and smear-negative as well as re-treatment
smear-positive cases registered in 2003, and about policies and practices in use for TB control. In
addition, data from drug resistance and TB-HIV surveillance were compiled.
Over a decade ago, WHO declared tuberculosis a “global emergency”, not only because of its
effect on individuals but also because of its wider social and economic ramifications on a country’s
development. Targets were established to measure the progress of implementation of the directly
observed treatment, short-course (DOTS) strategy to combat tuberculosis by 2005. These targets
include 100% population coverage with DOTS, 70% case detection and 85% treatment success
rate. Achieving these targets is an important intermediate step towards reaching the impact targets
of 50% reduction in prevalence and mortality due to TB by 2010, compared with 2000. Since 2000,
the Western Pacific Region has achieved significant progress:  DOTS coverage reached 94% at the
end of 2004; the Region has already achieved the cure rate target in DOTS areas; and it will likely
reach the 70% case detection target by the end of 2005.
The Western Pacific Region publishes an annual TB report sharing current knowledge on the state
of TB in the Region. Its primary aim is to present data on TB epidemiology and related information
reported from national TB control programmes (NTP). The annual report highlights the similarities
and differences within the Region and the strategies that have been adopted to address the TB
epidemic.
Introduction1
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Epidemiology2
This report is based on case notifications for 2004 and treatment outcomes for patients registered
in 2003, as reported by national TB control programmes to the World Health Organization in 2005,
using standard data collection forms, with common definitions and variables (Annex 1).
2.1 Estimated burden
Estimates of TB prevalence, incidence and mortality in countries are based on a consultative and
analytical process that takes into account all available information on case notifications; prevalence
of infection and disease; tuberculin surveys; duration of illness; proportion of smear-positive cases;
numbers of cases treated and remaining untreated; HIV prevalence and incidence; mortality and
demography. The estimates of disease burden are revised annually by WHO to reflect new
information gathered through surveillance and from special studies such as prevalence and annual
risk of tuberculosis infection (ARTI) studies conducted in countries. The estimates are also applied
to previous years, retrospectively, when necessary. The estimated figures are WHO provisional
estimates published in the WHO Report 2006: Global Tuberculosis Control. The methodology used
for case estimates was described in detail in the “Global Burden of Tuberculosis,”2 published in
1999, and “The Growing Burden of Tuberculosis,”3 published in 2003. In all measurements of TB
indicators, population estimates provided by the United Nations Population Division are used,4
recognizing that these sometimes differ from population data in the countries themselves (many of
which are based on more recent survey data).
In 2004, there were an estimated 3.8 million prevalent cases of TB (216 per 100 000 population) in
the Western Pacific Region, of which almost 2 million were new cases (111 per 100 000 population).
China accounted for about 70% of all incident TB cases (all forms) in the Region.
It was estimated that 307 411 deaths from tuberculosis occurred in the Region in 2004, i.e. 18
deaths from tuberculosis per 100 000 population.  The death rate from tuberculosis per 100 000
population was highest in Cambodia (94) as compared to 17 in China.
Table 1 shows the rates of change in the estimated prevalence and death rates from 2000 to 2004.
2 Dye C et al. Global Burden of Tuberculosis. Estimated Incidence, Prevalence, and Mortality by Country. Journal of the
American Medical Association , 1999, 282: 677–686.
3 Corbett EL et al. The Growing Burden of Tuberculosis. Global Trends and Interactions with the HIV Epidemic. Archives of
Internal Medicine , 2003, 163(9): 1009–1021.
4 World Population Prospects: The 2004 Revision Population Database.  New York, United Nations Population Division,
2005 (http://esa.un.org/unpp/, accessed January 2006).
TABLE 1:  ESTIMATED PREVALENCE RATES (ALL CASES) AND DEATH RATES PER 100 000 OF
TB IN THE WESTERN PACIFIC REGION
The estimated prevalence and death rates decreased in the Region at an overall yearly rate
of –4.8% and –2.7%, respectively.
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2.2 Case notification
2.2.1 Notifications
The population coverage with DOTS was 94% in the Western Pacific Region in 2004.
The Region detected 25% of the total number of cases detected globally. The Region accounted
for approximately 1.2 million cases of all forms of all notified cases of tuberculosis and 579 594
notified cases of smear-positive tuberculosis in 2004.  The largest number was from China, with
790 603 cases (384 886 smear-positive cases). Thus China alone accounted for 16% of all reported
tuberculosis cases and 17% of all smear-positive cases reported globally.5
2.2.2 Notification rates
The case notification rate per 100 000 population in the Western Pacific Region was 67 for 2004.
The notification rate for all cases in the Region has been steady since 1995. After a slight but
steady decline since 1996, the Region has experienced a more rapid increase in its notification
rate, from 47 to 67 per 100 000 between 2002 and 2004 (Figure 1).
5 Global tuberculosis control - surveillance, planning, financing. Geneva, World Health Organization, 2006 (WHO/HTM/TB/
2006.362).
The smear-positive notification rate for the Western Pacific Region held steady between 1998 and
2002, at 22 per 100 000. Since 2003, the Region has shown a comparative increase in the smear-
positive notification rate, to 33 per 100 000 (Figure 2).
FIGURE 1:  CASE NOTIFICATION RATES (ALL FORMS) IN THE WESTERN PACIFIC REGION,
1995–2004
FIGURE 2: CASE NOTIFICATION RATES OF SMEAR-POSITIVE CASES, 1995–2004
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2.2.3 Age- and sex-specific notification rates
The age- and sex-specific notification rates for the Region for 2004 show that males have higher
rates overall and display an upward trend in the higher age groups, indicating a shift in the
epidemiology of tuberculosis (see Figure 3).
FIGURE 3:  SMEAR-POSITIVE NOTIFICATION RATES, BY AGE AND SEX, 2004
2.3 TB-HIV
The HIV epidemic has reached a generalized stage at the national level in Cambodia and in
Papua New Guinea. The prevalence of HIV infection among TB was estimated to be 13% in
Cambodia and 3.7% in Papua New Guinea in 2004. In other countries affected by HIV,6 particularly
China and Viet Nam, the HIV epidemic is still at the concentrated stage. In China, HIV prevalence
data indicate a concentrated spread of infections among injecting drug users (IDUs) and no
significant spread to the non-IDU population. Although HIV/AIDS cases have been detected in all
provinces, HIV transmission is focused primarily among IDUs in certain provinces. In Viet Nam, the
prevalence is highest among IDUs (24% in 2000), but sexual transmission of HIV is increasing
among female sex workers.
Tuberculosis is the most important life-threatening opportunistic infection associated with HIV.
Table 2 shows the regional estimated prevalence of HIV among TB cases in countries with a high
TB burden. The overall estimated HIV seropositivity among new adult TB cases is 1.4% in the
Western Pacific Region.
6 Global Health Atlas (http://www.who.int/GlobalAtlas/PDFFactory/HIV/index.asp, accessed February 2005).
TABLE 2:  ESTIMATED PREVALENCE OF HIV IN NEW TB CASESa
a Detailed methodology and year 2000 estimates published in: Corbett EL et al. The Growing Burden of Tuberculosis:
Global Trends and Interactions with the HIV Epidemic. Archives of Internal Medicine, 2003, 163(9): 1009–1021.
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2.4 Drug resistance
Multidrug resistant-tuberculosis (MDR-TB) is posing a threat to tuberculosis control in several
countries.
In 1994, the Global Project on Anti-tuberculosis Drug Resistance Surveillance was launched by
WHO, the International Union Against TB and Lung Disease (The Union) and several other partners.
The Global Project methodology for drug resistance surveillance was designed around and continues
to operate on three main principles: (1) surveillance must be based on a sample of TB patients
representative of all cases in the geographical setting under evaluation; (2) drug resistance must
be clearly distinguished according to the treatment history of the patient in order to allow correct
interpretation of resistance data; and (3) optimal laboratory performance must be attained through
participation in a quality assurance programme, including the international exchange of strains of
Mycobacterium tuberculosis.
Drug resistance was present in all settings surveyed in the Western Pacific Region. The prevalence
of drug resistance varied widely across settings (Table 3). DOTS-Plus pilot programmes are already
implemented in the Philippines and in Mongolia, and are starting in two provinces of China.
TABLE 3:  ANTI-TUBERCULOSIS DRUG RESISTANCE, BY COUNTRY
aData from Australia are for combined cases.  bINH: Isoniazid; cMDR: multidrug resistance
Continuous monitoring of trends in high prevalence MDR settings is essential in order to assess
current interventions and their impact on the epidemic. To date, it is difficult to interpret trends in
high MDR prevalence settings with any certainty. No area reaching MDR prevalence of 6.5% has
dropped below that point in subsequent surveys, suggesting that, when a critical threshold of
transmission has been reached within a population, it may take a considerable amount of time to
reduce the prevalence of MDR-TB. The results of improved TB control interventions under DOTS,
and targeted interventions such as DOTS-Plus, may not be as rapidly evident in these settings as
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Progress in TB control3
3.1 DOTS coverage
Among the 37 countries and areas in the Western Pacific Region, all have had at least part of their
population covered by DOTS units. Figure 4 shows the DOTS population coverage achieved between
1995 and 2004.
FIGURE 4:  DOTS COVERAGE IN THE WESTERN PACIFIC REGION, 1995-2004
Much of the increase in population coverage in recent years is attributable to DOTS expansion in
China.
3.2 Case detection
The overall case detection rate (DOTS and non-DOTS) was 60% for all tuberculosis and 67% for
smear-positive cases (Table 4); DOTS areas reported 65% of all estimated new smear-positive
cases. Case detection has increased 29% between 2003 and 2004 in the Region.

























Smear-positive cases (%) % Increase (from 2003 to 2004)
Case detection rates
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Case detection made steady but slow progress in the Western Pacific Region until 2002. The increase
in case detection (+29%) in the Region between 2003 and 2004 is mostly due to a dramatic increase
in case detection in China (+44%). The global target of 70% case detection rate by the end of 2005
has likely been reached in the Region (Figure 5).
Note: The forecast line for the Western Pacific Region is based on preliminary data from 2005 (Q-DOTS quarterly reporting
to WHO).
3.3 DOTS enrolment and progress in overall case detection
Figure 6 shows trends in new smear-positive case detection rates in DOTS and non-DOTS areas in
the Region during the period 1995 to 2004. Regionally, the total case detection rate was stable
from 1997 to 2002, although there was rapid DOTS expansion during this period and rapid increase
to 2004.
FIGURE 6:  TRENDS IN DOTS AND NON-DOTS CASE DETECTION RATES (NEW SMEAR-POSITIVE
CASES) IN THE WESTERN PACIFIC REGION
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FIGURE 5:  TRENDS IN DOTS CASE DETECTION RATES OF SMEAR-POSITIVE CASES, 1995-2004
3.4 Treatment outcomes
Regionally, in DOTS areas, the cure and treatment success rates were 87% and 91%, respectively,
for the cohort of 426 675 new pulmonary smear-positive cases registered for treatment in 2003. The
regional TB control programme has reached the target of 85% cure rate. It is notable that reported
failure rates in both DOTS (1%) and non-DOTS (1%) areas are very low (Figure 7).
FIGURE 7:  TREATMENT OUTCOMES FOR NEW SMEAR-POSITIVE CASES REGISTERED IN 2003
IN DOTS AND NON-DOTS AREAS IN THE WESTERN PACIFIC REGION
FIGURE 8:  TREATMENT OUTCOMES FOR NEW SMEAR-POSITIVE CASES REGISTERED IN 2003
IN DOTS AREAS IN HIGH-BURDEN COUNTRIES
In total, 15 countries and areas out of 36 reported
treatment outcomes below the 85% global
target, including two countries with a high
burden of TB - The Lao People's Democratic
Republic and Papua New Guinea (Figure 8).
Non-DOTS areas reported a lower success rate
for treatment completion than DOTS areas.
Figure 9 shows the distribution of unfavourable
outcomes in the Region. Defaults (25%) and
deaths (25%) together accounted for half of all
unfavourable outcomes among new smear-
positive TB cases registered under DOTS
programmes in the Western Pacific Region in
2003.
9
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FIGURE 9:  UNFAVOURABLE OUTCOMES
AMONG NEW SMEAR-POSITIVE CASES
REGISTERED IN 2003 IN DOTS AREAS IN THE
WESTERN PACIFIC REGION
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3.5 Treatment results of re-treatment cases
Figure 10 shows treatment outcomes for re-treatment cases in the Western Pacific Region. The
high success rate among re-treatment cases in China accounted for the overall high treatment
success rate (87%) among re-treatment cases in the Western Pacific Region.
FIGURE 10:  TREATMENT OUTCOMES FOR
RE-TREATMENT CASES REGISTERED IN 2003
(DOTS AREAS)
3 | PROGRESS IN TB CONTROL
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Explanatory notes7
Regional summary and country data are presented in the following 12 tables.  All rates are per
100 000 population.
Table 5
Estimated burden of TB, 2000 and 2004
Estimates of incidence, prevalence and mortality for 2000 (baseline year for impact targets endorsed
by the Regional Committee) and 2004 (the latest year covered by this report). See Annexes 2 and
3 for details of calculations. All estimates include TB in people living with HIV.
Table 6
Whole country case notifications and case detection rates, 2004
Case notifications by history (new or re-treatment), by site (pulmonary or extrapulmonary) and by
smear status (smear-positive, smear-negative or unknown). Proportions of case types and estimated
case detection rate for whole country (DOTS and non-DOTS combined).
• Population, source:  World population prospects – the 2004 revision. New York; United Nations
Population Division, 2005.
• Country total:  the total number of TB cases according to the country’s own reporting convention
(in many countries this matches the WHO total – new and relapse; other countries include re-
treatment cases and/or cases with unknown treatment history).
• WHO total: new and relapse cases.
• Other new: new cases for which the site of disease is not recorded.
• Other retreat: re-treatment cases for which the outcome of previous treatment is not known.
• Other: cases for which neither treatment history nor site of disease is recorded.
• New pulm. lab. confirmed: new pulmonary cases in which diagnosis has been confirmed by
smear and/or culture examination.
• Detection rate, all cases: notified (new and relapse) cases divided by estimated incident cases
(expressed as a percentage).
• Detection rate, new SS+: notified new smear-positive cases divided by estimated incident
smear-positive cases (expressed as a percentage).
• SS+ (% of pulm.):  the percentage of all new pulmonary cases that are smear-positive.
• SS+ (% of new+relapse):  the percentage of new and relapse case that are new smear-positive.
• Extrapulm. (% of new+relapse): the percentage of all new and relapse cases that are
extrapulmonary.
• Retreat. (% of new+retreat.): notified re-treatment cases as a percentage of all notified cases.
Table 7
DOTS coverage, case notifications and case detection rates, 2004
• DOTS coverage: the percentage of the national population living in areas where health services
have adopted DOTS.
7 See Global tuberculosis control - surveillance, planning, financing. Geneva, World Health Organization, 2006 (WHO/HTM/
TB/2006.362).
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Table 8
Public–Public and Public–Private Mix (PPM), collaborative TB-HIV activities and management
of MDR-TB, 2003–2004
Public–Public and Public–Private Mix (PPM)
• Guidelines for other practitioners:
— In the final row of the data table, numbers represent the proportion of countries in the
Region that have guidelines for management of TB for practitioners working outside public
health clinics.
— “Yes” or “No” indicates whether guidelines for TB management are available for practitioners
working outside public health clinics.
• Institutions notifying NTP:
— In the final row of the data table, the numbers represent the proportion of countries in the
Region where at least some providers of a particular type notified TB cases to the NTP in
2004.
— “All”, “Some” or “None” indicates whether any providers of a particular type notified TB
cases to the NTP in 2004.
Collaborative TB-HIV activities
• HIV testing for TB patients (pts):
— In the final row of the data table, the numbers represent the proportion of countries in the
Region that implemented, at least partially, a national policy of offering HIV testing and
counselling to TB pts.
— “Yes” indicates that the country implemented a national policy of offering HIV testing and
counselling to all TB patients in 2004; “Partially” indicates that the policy was implemented
in part of the country.
• HIV surveillance among TB pts:
— In the final row of the data table, the numbers represent the proportion of countries in the
Region that have a national system for HIV surveillance among TB patients.
— “Yes” or “No” indicates whether the country has a national system for HIV surveillance
among TB patients.
• TB pts tested for HIV: the number of TB patients tested for HIV in 2003.
• TB pts HIV-positive: the number of TB patients found to be HIV-positive in 2003.
• TB pts CPT: the number of HIV-positive TB patients given co-trimoxazole preventive therapy in
2003.
• TB pts ART: the number of HIV-positive TB patients given antiretroviral therapy during their TB
treatment in 2003.
Multidrug resistant-TB
• Laboratory-confirmed MDR: number of laboratory-confirmed cases of MDR-TB identified among
TB patients diagnosed in 2004.
• DST in new cases: number of new TB cases in 2004 for which drug sensitivity testing (DST)
was performed at start of treatment.
• MDR in new cases: number of new cases identified as MDR-TB based on DST at start of
treatment.
• Re-treatment DST: number of re-treatment cases registered in 2004 for which DST was performed
at start of treatment.
• Re-treatment MDR: number of re-treatment cases identified as MDR-TB.
Table 9
Treatment outcomes, 2003 cohort
Treatment outcomes of new smear-positive cases treated under DOTS, non-DOTS and re-treatment
cases under DOTS.
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Table 10
Re-treatment outcomes, 2003 cohort
Re-treatment outcomes of smear-positive cases treated under DOTS after relapse, treatment failure
or default.
Table 11
DOTS treatment success and case detection rates, 1994–2004
Treatment success rates (the proportion of registered cases cured or completed treatment) for new
smear-positive cases treated under DOTS from 1994 to 2003 and smear-positive case detection
rates under DOTS from 1995 to 2004.
Table 12
New smear-positive case notification by age and sex, absolute numbers, DOTS and non-
DOTS, 2004
Breakdown by age and sex of new smear-positive cases notified from whole country (DOTS and
non-DOTS). Some countries cannot provide the breakdown for all smear-positive notified cases.
Table 13
New smear-positive case notification rates by age and sex, DOTS and non-DOTS, 2004
Notification rates of new smear-positive cases by age and sex (DOTS + non-DOTS). Rates are
missing where breakdown of smear-positive notified cases is not provided, or when age- and sex-
specific population data are not available.
In the regional summary row, rates exclude those countries for which breakdown of notified cases
or population by age and sex is missing.
Table 14
Number of TB cases notified, 1980–2004
Table 15
Case notification rates, 1980–2004
Table 16
New smear-positive cases notified, numbers and rates, 1993–2004
TABLES
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Incidence, 2000 Prevalence, 2000 TB mortality, 2000
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate






All formsa All forms
HIV+
All formsa All forms
HIV+
Incidence, 2004 Prevalence, 2004 TB mortality, 2004






All formsa All forms
HIV+
All formsa All forms
HIV+
a Incidence, prevalence and mortality estimates include patients with HIV. Estimates labelled "HIV+" are estimates of TB in HIV-positive adults (ages 15-49 years). Estimates for all years are recalculated as new information
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TABLE 6: WHOLE COUNTRY CASE NOTIFICATIONS AND CASE DETECTION RATES, 2004
(SS+) — sputum smear-positive; (SS–) — sputum smear-negative; unk. — sputum smear result unknown; retreat. — re-treatment; pulm. lab. confirmed — pulmonary case confirmed by positive smear or culture. See Explanatory
notes for further details. Data can be downloaded from http://stoptb.wpro.who.int.
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TABLE 7: DOTS COVERAGE, CASE NOTIFICATIONS AND CASE DETECTION RATES, 2004
(SS+) — sputum smear-positive; (SS–) — sputum smear-negative; unk.— sputum smear result unknown; retreat. — re-treatment; pulm. lab. confirmed — pulmonary case confirmed by positive smear or culture. See Explanatory
notes for further details. Data can be downloaded from http://stoptb.wpro.who.int.
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TABLE 8: PUBLIC-PUBLIC AND PUBLIC-PRIVATE MIX (PPM), COLLABORATIVE TB-HIV ACTIVITIES AND MANAGEMENT OF MDR-TB, 2003-2004
ART — antiretroviral therapy; CPT — co-trimoxazole preventive therapy; pts — patients; DST — Drug susceptibility testing; MDR — Multidrug resistance. The regional row for the first nine columns represents the proportion of
countries that provided an affirmative response ("Yes", "All", "Some" or "Partially"). See Explanatory notes on page 12 for further details. Some countries provided the number of TB patients found to be HIV-positive, but did not
provide the number of TB patients tested. The regional total of TB patients tested is therefore lower than the number of patients actually tested, and cannot be used to calculated a regional estimate of HIV prevalence in TB patients.
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TABLE 9: TREATMENT OUTCOMES, 2003 COHORT
Not eval. — not evaluated (percentage of registered cases for which outcomes were not recorded); success — sum of cured and completed; cases regist'd — the denominator for calculating treatment outcomes. The number of
cases registered for treatment in 2003 is the denominator for calculating treatment outcomes unless it is less than the sum of outcomes, in which case the sum of outcomes is used. If the number of cases registered is not reported,
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TABLE 10: RE-TREATMENT OUTCOMES, 2003 COHORT
Not eval. — indicates not evaluated (percentage of registered cases for which outcomes were not recorded); success, sum of cured and completed; cases regist'd — the denominator for calculating treatment outcomes. The
number of cases registered for treatment in 2003 is used as the denominator for calculating treatment outcomes unless it is missing or is less than the sum of outcomes, in which case the sum of outcomes is used. Data can be
downloaded from http://stoptb.wpro.who.int.
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DOTS new smear-positive treatment success (%)
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
DOTS new smear-positive case detection rate (%)

















































































































































































































































































































































































































































































































Treatment success — sum of cured and completed; DOTS new smear-positive case detection rate — notified (new and relapse) cases divided by estimated incident cases. The table includes updated information; data shown here
may differ from that published in previous reports. Data can be downloaded from http://stoptb.wpro.who.int.
TABLE 11: DOTS TREATMENT SUCCESS AND CASE DETECTION RATES, 1994-2004
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For some countries, breakdown of notified cases by age and sex is missing, or is provided for only a subset of cases. Data can be downloaded from http://stoptb.wpro.who.int.
TABLE 12: NEW SMEAR-POSITIVE CASE NOTIFICATION BY AGE AND SEX, ABSOLUTE NUMBERS, DOTS AND NON-DOTS, 2004
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Male Female All



















































































































































































































































































































































































































































































































Rates are per 100 000 population of each age/sex group. Rates are calculated excluding those countries for which breakdown of notified cases or population by age and sex is missing. Data can be downloaded from
http://stoptb.wpro.who.int.
TABLE 13: NEW SMEAR-POSITIVE CASE NOTIFICATION RATES BY AGE AND SEX, DOTS AND NON-DOTS, 2004
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From 1995, number shown is all notified new and relapse cases (DOTS and non-DOTS). The table includes updated information; data shown here may differ from that published in previous reports. Data can be downloaded from
http://stoptb.wpro.who.int.
TABLE 14: NUMBER OF TB CASES NOTIFIED, 1980-2004
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Rates are per 100 000 population. The table includes updated information; data shown here may differ from those published in previous reports. Data can be downloaded from http://stoptb.wpro.who.int
TABLE 15: CASE NOTIFICATION RATES, 1980-2004
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TABLE 16: NEW SMEAR-POSITIVE CASES NOTIFIED, NUMBERS AND RATES, 1993-2004
Number of cases



































































































































































































































































































































































































































Rate (per 100 000 population)






























































































































































































































































































































































































Rates are per 100 000 population. The table includes updated information; data shown here may differ from those published in previous reports. Data can be downloaded from http://stoptb.wpro.who.int
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ANNEX 1. Definitions8
1. Definitions of tuberculosis cases
A case of tuberculosis: A patient in whom tuberculosis has been bacteriologically confirmed or
has been diagnosed by a clinician. Any person given treatment for tuberculosis should be recorded.
All types: The sum of new smear-positive pulmonary, relapse, new smear-negative pulmonary and
extrapulmonary cases.
New smear-positive pulmonary tuberculosis: A patient who has never received treatment for
tuberculosis, or who has taken anti-tuberculosis drugs for less than 30 days and who has one of
the following:
• two or more initial sputum smear examinations positive for acid fast bacilli (AFB);
• one sputum examination positive for AFB plus radiographic abnormalities consistent with
active pulmonary tuberculosis as determined by a clinician; or
• one sputum specimen positive for AFB and at least one sputum that is culture-positive for
AFB.
New smear-negative pulmonary tuberculosis: A case of pulmonary tuberculosis that does not
meet the above definition for smear-positive tuberculosis.
Extrapulmonary tuberculosis: Tuberculosis of organs other than the lungs, e.g. pleura, lymph
nodes, abdomen, genito-urinary tract, skin, joints, bones, meninges. Diagnosis should be based
on one culture-positive specimen, or histological or strong clinical evidence consistent with active
extrapulmonary tuberculosis, followed by a decision by a clinician to treat with a full course of anti-
tuberculosis chemotherapy. (A patient diagnosed with both pulmonary and extrapulmonary
tuberculosis should be classified as a case of pulmonary tuberculosis.)
Re-treatment case: Patient previously treated for tuberculosis, undergoing treatment for a new
episode of bacteriologically positive (sputum smear or culture) tuberculosis.
Relapse: A patient previously treated for tuberculosis and declared cured or treatment completed,
who is later diagnosed with bacteriologically positive (culture smear) tuberculosis.
2. Definitions of treatment outcome
Cured: Former smear-positive patient who was smear-negative in the last month of treatment, and
on at least one previous occasion.
Completed treatment: A patient who has completed treatment but who does not meet the criteria
to be classified either as a cure or a failure.
ANNEXES
8 World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis
Association. Revised international definitions in tuberculosis control. The International Journal of Tuberculosis and Lung
Disease, 2001, 5(3): 213–215.
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Treatment success: The sum of patients who are cured and those who have completed treatment.
Died: A patient who dies for any reason during the course of treatment.
Failure: Smear-positive patient who remained smear-positive at five months or later during treatment.
Defaulted: A patient who has interrupted treatment for two consecutive months or more.
Transferred out: A patient who has been transferred to another recording and reporting unit and
for whom the treatment outcome is not known.
Not evaluated: A patient who did not have the treatment outcome evaluated.
Note: In countries where culture is current practice, patients can be classified as
cured or failed based on the culture results.
3. Indicators to assess treatment outcome
Cure rate: Proportion of cured cases out of all cases registered in a given period (2002, in this
report).
Treatment success rates: The sum of the proportion of patients who were cured and patients who
completed treatment out of all cases registered in a given period. The global target is an 85% cure
rate and a greater treatment success rate.
The cure rate and treatment success rate are expressed as a percentage of registered cases. The
number of new cases registered for treatment in 2003 (reported in 2004) is compared with the
number of cases notified as smear-positive in 2002 (reported in 2003). Differences may arise because
national TB control programmes (NTP) do not compile data at the end of each calendar year,
diagnosis may be incorrect, patients are lost between diagnosis and the start of treatment, or
records may be lost. All registered cases should be evaluated. Data on the six standard, mutually
exclusive outcomes of treatment are compiled. These figures are reported as percentages of all
registered cases, so that the possible outcomes plus the fraction of cases not evaluated add up to
100%. When a country states the number of patients registered for treatment, but gives no outcomes,
no result is reported, rather than reporting zero treatment success. Although treatment outcomes
are expressed as percentages, they are referred to as rates. The six possible outcomes plus the
fraction of cases not evaluated sum up to 100%. If the number of registered cases is lower than the
sum of the six outcomes or is missing, the denominator for treatment success will be the number
evaluated or the number of smear-positive cases notified in the previous year, whichever is greater.
4. Case detection rate and DOTS detection rate
DOTS
The recommended strategy for tuberculosis control is comprised of:
• Government commitment to ensuring sustained, comprehensive tuberculosis control
activities.
• Case detection by sputum smear microscopy among symptomatic patients self-reporting
to health services.
• Standardized short-course chemotherapy using regimens of six to eight months, for at
least all confirmed smear-positive cases. Good case management includes directly
observed treatment during the intensive phase for all new sputum smear-positive cases,
the continuation phase of rifampicin-containing regimens and the whole re-treatment
regimen.
• A regular, uninterrupted drug supply of all essential anti-tuberculosis drugs.
ANNEXES
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ANNEXES
• A standardized recording and reporting system that allows assessment of case-finding
and treatment results for each patient and of the tuberculosis control programme
performance overall.
Targets for tuberculosis control established by the World Health Assembly (1991)
• To cure 85% of the sputum smear-positive tuberculosis cases detected.
• To detect 70% of the estimated new sputum smear-positive tuberculosis cases.
Case notifications represent only a fraction of the true number of cases in a country because the
coverage by effective NTP may be incomplete.
The estimated case detection rate is defined as:
Case detection rate (%) =
DOTS detection rate refers to case detection under DOTS:
DOTS detection rate (%) =
The case detection rate and DOTS detection rate are identical when a country has a 100% DOTS
enrolment rate. Updated estimated incidence for 2003 used in this report was provided by WHO.
Population with access to DOTS: The country’s population that lives in administrative areas where
DOTS services are available.
DOTS enrolment rate (%): This rate indicates a proportion of cases enrolled in DOTS, out of
notified cases.
DOTS enrolment rate (all types) (%) =
DOTS enrolment rate (new SS+) (%) =
Annual new smear-positive notifications under DOTS
Estimated annual new smear-positive incidence (country)
Annual new smear-positive notifications (country)
Estimated annual new smear-positive incidence (country)
Annual notifications of all types under DOTS
Total annual notifications of all types
Annual notification of new SS+ under DOTS
Total annual notifications of new SS+
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ANNEX 2. Formulas for estimating tuberculosis incidence, prevalence
and deaths
Source: Corbett EL et al. The Growing Burden of Tuberculosis. Global Trends and Interactions with the HIV Epidemic.
Archives Internal Medicine, 2003, 163(9): 1009-1021.
ANNEXES
1. I = T/d and Is= Ts/ds N = Population
I = Incidence of TB (number of new cases
of TB per year
2. P = tl and Ps= tsls P = Prevalence of TB
3. Is/N = lk T = TB case notifications (per year)
D = Deaths from TB
4. D = fl and Ds= fls IRR = TB incidence rate ratio (TB incidence
rate in HIV-positive persons/TB incidence
in HIV-negative persons)
5. I = Ia
++Ia








-+mnrnNn t = Average duration of TB disease (years)
l = Rate of infection with Mycobacterium
tuberculosis (MTB) (annual rate of infection
per person per year)
k = Ratio of incidence of smear-positive TB
to rate of MTB infection








-) t = Proportion of TB patients who die from TB
(case fatality rate [CFR])




+/Na)(IRR-1)] r = Rate of progression to TB disease in
MTB- infected individuals (per person per year)
s = Sputum smear-positive TB (no subscript











*) + = HIV-positive
- = HIV-negative
* = Attributable to HIV infection
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ANNEX 3. Statistical methods
Rates of change per year in the time series were assessed by estimating the slope of the log-
transformed rates against time.
The statistical analysis was carried out using the R language,9 available at no charge off the Internet.10
9 Ihaka R and Gentleman R. A language for data analysis and graphics. Journal of Computational and Graphical Statistics,
1996, 5(3): 299–314.
10 The R Project for Statistical Computing (http://www.r-project.org).
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